Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis

Ambar Chakravarty1

  • 1Department of Neurology, Vivekananda Institute of Medical Sciences, 59 Beadon Street, Calcutta 700006, India. saschakra@yahoo.com

Medical Hypotheses
|October 19, 2004
PubMed

Insights

This study proposes a unifying concept linking Alzheimer's disease (AD), vascular dementia (VD), and normal pressure hydrocephalus (NPH). Altered cerebrospinal fluid (CSF) dynamics and hypoperfusion may interconnect these common elderly dementias.

Area of Science:

  • Neurology
  • Neuroscience
  • Geriatrics

Background:

  • Alzheimer's disease (AD), vascular dementia (VD), and normal pressure hydrocephalus (NPH) are common dementias in the elderly.
  • These conditions often present with overlapping clinical and imaging features, complicating diagnosis.
  • Current understanding often treats these pathologies separately, despite potential interconnections.

Purpose of the Study:

  • To propose a unifying concept for the pathophysiology of AD, VD, and NPH.
  • To explain the overlapping clinical and neuroimaging features observed in these dementia types.
  • To explore potential therapeutic implications arising from a unified understanding.

Main Methods:

  • Review and synthesis of existing research on cerebrospinal fluid (CSF) dynamics.
  • Analysis of proposed links between CSF dynamics, amyloid deposition, and hypoperfusion.
  • Hypothesizing a unified model integrating AD, VD, and NPH pathogenesis.

Main Results:

  • Altered CSF dynamics may contribute to hydrocephalic changes and impaired amyloid clearance, linking NPH and AD pathology.
  • Defective amyloid clearance can lead to amyloid angiopathy, perpetuating hypoperfusion and linking AD and VD.
  • Hypoperfusion impacts CSF dynamics and amyloid clearance, further interconnecting AD, VD, and NPH.

Conclusions:

  • A unifying concept suggests that altered CSF dynamics and hypoperfusion are interlinked in the pathogenesis of AD, VD, and NPH.
  • This interconnectedness may explain the observed overlapping features of these dementia types.
  • Identifying patients with a potential AD-NPH syndrome could benefit from CSF drainage procedures.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...